Recommendations

This is a paper for discussion. This does not represent the views of the Committee and should not be cited.

35.               EFSA recommended that for the quantification of active and non-active lectins, the development and validation of analytical methods was needed. In addition to this, studies using PHA were needed for information on absorption, distribution, metabolism, and excretion (ADME), immunotoxicity, and gastrointestinal endpoints in humans and rodents. Further information was also required for an in-depth exposure assessment.